Advanced Search

Pathology/Lab Coding Alert

CCI 19.2:

Choose Specific Codes for Consultation, Bladder Tumor

Published on Fri Jul 05, 2013

Know when you can override edits. If your lab performs bladder tumor tests or molecular pathology procedures, you need to know about additions to Medicare’s Correct Coding Initiative (CCI) version 19.2, which takes effect July 1, 2013. Good news: Lab and pathology practices have few new edit pairs to worry about this time around, even though in version 19.2, "the [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Pathology/Lab Coding Alert

View All